Ritholtz Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Ritholtz Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Sell	8,100 -183	-2%	-$6.25K	﹤0.01%	1067
2026 Q1	$274K	Buy	8,283 +2,150	+35%	+$91K	﹤0.01%	1018
2025 Q4	$284K	Sell	6,133 -212	-3%	-$8.87K	0.01%	919
2025 Q3	$222K	Sell	6,345 -1,933	-23%	-$67.2K	﹤0.01%	941
2025 Q2	$245K	Sell	8,278 -23,830	-74%	-$680K	0.01%	862
2025 Q1	$958K	Sell	32,108 -1,676	-5%	-$51.2K	0.03%	411
2024 Q4	$968K	Sell	33,784 -10,405	-24%	-$344K	0.03%	367
2024 Q3	$1.71M	Buy	44,189 +5,333	+14%	+$190K	0.05%	260
2024 Q2	$1.25M	Buy	38,856 +11,699	+43%	+$406K	0.04%	296
2024 Q1	$1.05M	Buy	27,157 +17,872	+192%	+$625K	0.04%	346
2023 Q4	$286K	Buy	+9,285	New	+$233K	0.01%	611
2023 Q2	–	Sell	-10,363	Closed	-$249K	–	674
2023 Q1	$249K	Buy	+10,363	New	+$275K	0.01%	563

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ritholtz Wealth Management's COLL Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Collegium Pharmaceutical (COLL) stake by 2.2% in Q2 2026, selling an estimated $6.25K and leaving 8,100 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Ritholtz Wealth Management first reported a position in COLL in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.71M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Ritholtz Wealth Management held 8,100 shares of Collegium Pharmaceutical worth $293K as of Q2 2026.
Ritholtz Wealth Management sold 183 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.25K.
Collegium Pharmaceutical made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #1067 holding.
Ritholtz Wealth Management first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 12 quarters since.
Ritholtz Wealth Management's Collegium Pharmaceutical position peaked at $1.71M in Q3 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.